Pacer Advisors Inc. decreased its stake in shares of Gilead Sciences, Inc. ( NASDAQ:GILD – Get Rating ) by 0.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 2,625,845 shares of the biopharmaceutical company's stock after selling 15,231 shares during the quarter. Gilead Sciences accounts for 1.2% of Pacer Advisors Inc.'s holdings, making the stock its 4th largest position. Pacer Advisors Inc.'s holdings in Gilead Sciences were worth $225,429,000 at the end of the most recent quarter.

https://www.dailypolitical.com/2023/04/25/pacer-advisors-inc-has-225-43-million-stock-position-in-gilead-sciences-inc-nasdaqgild.html

#dailypolitical